Oct 15 (Reuters)- AFC-HD Ams Life Science Co Ltd CONSOLIDATED FINANCIAL HIGHLIGHTS (in billions of yen unless specified) Year ended Year ended Year to NEXT Aug 31, 2025 Aug 31, 2024 Aug 31, 2026 YEAR LATEST YEAR-AGO COMPANY COMPANY RESULTS RESULTS FORECAST H1 FORECAST Sales 32.66 30.19 34.14 16.73 (+8.2 pct) (+18.0 pct) (+4.5 pct) (+0.7 pct) Operating 2.41 1.92 2.55 1.30 (+25.7 pct) (+17.1 pct) (+5.6 pct) (+0.1 pct) Recurring 2.44 1.92 2.45 1.33 (+27.2 pct) (+16.2 pct) (+0.1 pct) (+0.1 pct) Net Net 1.45 1.25 1.46 883 mln (+15.7 pct) (+13.6 pct) (+1.0 pct) (+0.1 pct) EPS 102.98 yen 89.20 yen 103.73 yen 59.11 yen EPS Diluted 102.97 yen 89.11 yen Ann Div 34.00 yen 30.00 yen 36.00 yen -Q2 Div 16.00 yen 15.00 yen 18.00 yen -Q4 Div 18.00 yen 15.00 yen 18.00 yen NOTE - AFC-HD Ams Life Science Co Ltd. *Second Net profit row denotes profit attributable to owners ofthe parent To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2927.T